m6A-immune-related lncRNA prognostic signature for predicting immune landscape and prognosis of bladder cancer
出版年份 2022 全文链接
标题
m6A-immune-related lncRNA prognostic signature for predicting immune landscape and prognosis of bladder cancer
作者
关键词
-
出版物
Journal of Translational Medicine
Volume 20, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-10-29
DOI
10.1186/s12967-022-03711-1
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Cancer statistics, 2022
- (2022) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Down-regulation of ZNF252P-AS1 alleviates ovarian cancer progression by binding miR-324-3p to downregulate LY6K
- (2022) Li Geng et al. Journal of Ovarian Research
- An immune-related lncRNA model for predicting prognosis, immune landscape and chemotherapeutic response in bladder cancer
- (2022) Jian Hou et al. Scientific Reports
- Knockdown of lncRNA ZNRD1-AS1 suppresses gastric cancer cell proliferation and metastasis by targeting the miR-9-5p/HSP90AA1 axis
- (2021) Ming-Chen Ba et al. Aging-US
- Development of a Ferroptosis-Related lncRNA Signature to Predict the Prognosis and Immune Landscape of Bladder Cancer
- (2021) Ranran Zhou et al. DISEASE MARKERS
- RNA m6A demethylase FTO-mediated epigenetic up-regulation of LINC00022 promotes tumorigenesis in esophageal squamous cell carcinoma
- (2021) Yuanbo Cui et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The role of M6A modification in the regulation of tumor-related lncRNAs
- (2021) Yufei Lan et al. Molecular Therapy-Nucleic Acids
- N6-Methylandenosine-Related lncRNAs Predict Prognosis and Immunotherapy Response in Bladder Cancer
- (2021) Yuying Zhang et al. Frontiers in Oncology
- lncRNA THAP7-AS1, transcriptionally activated by SP1 and post-transcriptionally stabilized by METTL3-mediated m6A modification, exerts oncogenic properties by improving CUL4B entry into the nucleus
- (2021) Hai-Ting Liu et al. CELL DEATH AND DIFFERENTIATION
- Interaction between N6-methyladenosine (m6A) modification and noncoding RNAs in cancer
- (2020) Yi Chen et al. Molecular Cancer
- The emerging molecular mechanism of m6A modulators in tumorigenesis and cancer progression
- (2020) Shuiping Liu et al. BIOMEDICINE & PHARMACOTHERAPY
- Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer
- (2020) Andrea Necchi et al. EUROPEAN UROLOGY
- Novel insights into the interplay between m6A modification and noncoding RNAs in cancer
- (2020) You-Cai Yi et al. Molecular Cancer
- The Critical Role of RNA m6A Methylation in Cancer
- (2019) Qing Lan et al. CANCER RESEARCH
- The role of m6A RNA methylation in cancer
- (2019) Ting Sun et al. BIOMEDICINE & PHARMACOTHERAPY
- The role of m6A RNA methylation in human cancer
- (2019) Xiao-Yu Chen et al. Molecular Cancer
- The Tumor Immune Microenvironment Drives a Prognostic Relevance that Correlates with Bladder Cancer Subtypes
- (2019) Carolin Pfannstiel et al. Cancer Immunology Research
- Reading, writing and erasing mRNA methylation
- (2019) Sara Zaccara et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- A review on the role of M2 macrophages in bladder cancer; pathophysiology and targeting
- (2019) Laleh Sharifi et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- The interplay between m6A RNA methylation and noncoding RNA in cancer
- (2019) Shuai Ma et al. Journal of Hematology & Oncology
- Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation
- (2018) Tathiane M. Malta et al. CELL
- Long noncoding RNA BLACAT2 promotes bladder cancer–associated lymphangiogenesis and lymphatic metastasis
- (2018) Wang He et al. JOURNAL OF CLINICAL INVESTIGATION
- Long Noncoding RNA LBCS Inhibits Self-Renewal and Chemoresistance of Bladder Cancer Stem Cells through Epigenetic Silencing of SOX2
- (2018) Xu Chen et al. CLINICAL CANCER RESEARCH
- Exosome–transmitted long non-coding RNA PTENP1 suppresses bladder cancer progression
- (2018) Rui Zheng et al. Molecular Cancer
- LncRNA-mediated regulation of cell signaling in cancer
- (2017) W-X Peng et al. ONCOGENE
- Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
- (2017) Pornpimol Charoentong et al. Cell Reports
- Role of tumor microenvironment in tumorigenesis
- (2017) Maonan Wang et al. Journal of Cancer
- Biomarkers for immunotherapy in bladder cancer: a moving target
- (2017) David H. Aggen et al. Journal for ImmunoTherapy of Cancer
- From junk to master regulators of invasion: lncRNA functions in migration, EMT and metastasis
- (2016) Sonam Dhamija et al. INTERNATIONAL JOURNAL OF CANCER
- Robust enumeration of cell subsets from tissue expression profiles
- (2015) Aaron M Newman et al. NATURE METHODS
- Drug-Resistant Urothelial Cancer Cell Lines Display Diverse Sensitivity Profiles to Potential Second-Line Therapeutics
- (2015) Stefan Vallo et al. Translational Oncology
- LncRNA: A link between RNA and cancer
- (2014) Guodong Yang et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy
- (2014) Woonyoung Choi et al. CANCER CELL
- Tumor-Associated Macrophages: From Mechanisms to Therapy
- (2014) Roy Noy et al. IMMUNITY
- Long Noncoding RNA in Prostate, Bladder, and Kidney Cancer
- (2013) Elena S. Martens-Uzunova et al. EUROPEAN UROLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started